Crowe, John P.

Publishing since 2005 (Junior)

Has published 10 publications in 5 years

Number of publications published per year by Crowe, John P.. (Source : PubMed)

Distribution of publications types for Crowe, John P.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Richardsen E, Sørbye SW, Crowe JP, Yang JL, Busund LT. Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.  Anticancer Res.  2009;29;10  
•  Smedira HJ, Patrick RJ, Rybicki LA, Crowe JP. Integrating medical breast specialists into the traditional breast center practice model: a review of 11 years of experience.  Arch. Intern. Med.  2008;168;18  
•  Escobar PF, Patrick RJ, Rybicki LA, Weng DE, Crowe JP. The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups.  Annals of surgical oncology  2007;14;1  
•  Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, Choueiri TK, Tubbs RR, Gaile D, Nowak N, Accavitti-Loper MA, Frost AR, Welch DR, Casey G. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.  Clin. Cancer Res.  2006;12;22  
•  Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, Tubbs RR, Casey G, Weil RJ. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.  Am. J. Surg. Pathol.  2006;30;9  
•  Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.  Annals of surgical oncology  2006;13;6  
•  Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.  J. Clin. Oncol.  2006;24;9  
•  Haka AS, Volynskaya Z, Gardecki JA, Nazemi J, Lyons J, Hicks D, Fitzmaurice M, Dasari RR, Crowe JP, Feld MS. In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy.  Cancer Res.  2006;66;6  
•  Hicks DG, Dawson A, Mattingly S, Crowe JP. The unmet clinical need for new molecular genetic markers in the prognosis and therapeutic management of breast cancer.  Arch. Pathol. Lab. Med.  2005;129;11  
•  Hicks DG, Yoder BJ, Pettay J, Swain E, Tarr S, Hartke M, Skacel M, Crowe JP, Budd GT, Tubbs RR. The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.  Hum. Pathol.  2005;36;4  

[ See timeline ] [ See all publications ]